2015
Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children
Arbizu RA, Rodriguez L. Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children. World Journal Of Gastrointestinal Endoscopy 2015, 7: 433-437. PMID: 25992183, PMCID: PMC4436912, DOI: 10.4253/wjge.v7.i5.433.Commentaries, Editorials and LettersGastrointestinal motility disordersMotility disordersBotulinum toxin type APatients 12 yearsToxin type AExcessive neural activityTreatment of strabismusBotulinum neurotoxin type AType ANeurotoxin type ABowel perforationPresynaptic releaseTherapeutic applicationsClostridium botulinum toxinSignificant complicationsMinor painCentral originBotulinum toxinGastroenterological conditionsAllergic reactionsParalytic diseaseSignificant paralysisGastrointestinal tractObligate anaerobic bacteriaClinical experience
2014
Gastrointestinal motility disorders in children.
Ambartsumyan L, Rodriguez L. Gastrointestinal motility disorders in children. Gastroenterology & Hepatology 2014, 10: 16-26. PMID: 24799835, PMCID: PMC4008955.Peer-Reviewed Original ResearchGastrointestinal motility disordersGastroesophageal reflux diseaseCommon gastrointestinal motility disordersMotility disordersEsophageal achalasiaSignificant morbidityPneumatic balloon dilationPediatric patient populationNew diagnostic techniquesReflux diseaseBalloon dilationPatient populationCommon complaintClinical trialsCommon disorderSecretion blockadeDisordersConstipationGastroparesisAchalasiaMorbidityChildrenDiagnostic techniquesPoor qualityEsophagomyotomy